Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling

Stem Cells

Volumn 30, Issue 11, 2012, Pages 2498-2511

  Wan, Mei ^a   Li, Changjun ^a   Zhen, Gehua ^a   Jiao, Kai ^a,b   He, Wenying ^a,c   Jia, Xiaofeng ^a   Wang, Weishan ^c   Shi, Chenhui ^c   Xing, Qiujuan ^a,d   Chen, Yiu Fai ^e   De Beur, Suzanne Jan ^a   Yu, Bing ^a   Cao, Xu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHIHEZI UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e University of Alabama at Birmingham   (United States)

Author keywords

Cell mobilization; Mesenchymal stem cells; TGF activation; Vascular remodeling

Indexed keywords

ATAXIN 1; BETA1 INTEGRIN; CD11B ANTIGEN; CD45 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMORAL ARTERY; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; RAT; STEM CELL MOBILIZATION; TISSUE INJURY; TISSUE REPAIR; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIES; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NEOINTIMA; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; WOUND HEALING;

EID: 84867919298     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1208     Document Type: Article

References (71)

1. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530. (Pubitemid 28217075)
2. Takahashi T, Kalka T, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438. (Pubitemid 29180584)
3. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
4. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-10349. (Pubitemid 32803022)
5. Kale S, Karihaloo A, Clark PR et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112:42-49. (Pubitemid 38056374)
6. Orlic D et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705. (Pubitemid 32290358)
7. Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407-8411. (Pubitemid 36842558)
8. Sato Y, Araki H, Kato J et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-763. (Pubitemid 40981278)
9. Rochefort GY, Delorme B, Lopez A et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 2006;24:2202-2208. (Pubitemid 44527473)
10. Oh JY, Kim MK, Shin MS et al. The anti-inflammatory and antiangiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008;26:1047-1055.
11. Sasaki M, Abe R, Fujita Y et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008;180:2581-2587.
12. Hong HS, Lee J, Lee E et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med 2009;15:425-435.
13. Quevedo HC, Hatzistergos KE, Oskouei BN et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009;106:14022- 14027.
14. Wojakowski W, Landmesser U, Bachowski R et al. Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 2012;36:23-33.
15. Krankel N, Spinetti G, Amadesi S e al. Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther 2011;129:62-81.
16. Schraufstatter IU, Discipio RG, Khaldoyanidi S. Mesenchymal stem cells and their microenvironment. Front Biosci 2011;17:2271-2288.
17. Caplan AI, Correa D. The MSC: An injury drugstore. Cell Stem Cell 2011;9:11-15.
18. Kanzaki T, Shiina R, Saito Y et al. Role of latent TGF-beta 1 binding protein in vascular remodeling. Biochem Biophys Res Commun 1998;246:26-30. (Pubitemid 28413920)
19. Munger JS, Harpel JG, Gleizes PE et al. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 1997;51:1376-1382. (Pubitemid 27239886)
20. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003;116:217-224. (Pubitemid 36163863)
21. Tang Y, Wu X, Lei W et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009;15:757-765.
22. Pittet JF, Griffiths MJ, Geiser T et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-1544. (Pubitemid 32574640)
23. Sinha S, Heagerty AM, Shuttleworth CA et al. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 2002;53:971-983. (Pubitemid 34261035)
24. Kim KK, Kugler MC, Wolters PJ et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185. (Pubitemid 44338936)
25. Ahamed J, Burg N, Yoshinaga K et al. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood 2008;112:3650-3660.
26. Brunner G, Blakytny R. Extracellular regulation of TGF-beta activity in wound repair: Growth factor latency as a sensor mechanism for injury. Thromb Haemost 2004;92:253-261. (Pubitemid 39172305)
27. Qi YX, Jiang J, Jiang XH et al. PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc Natl Acad Sci USA 2011;108:1908-1913.
28. Ohno M, Cooke JP, Dzau VJ et al. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest 1995;95:1363-1369.
29. Grainger DJ. Transforming growth factor beta and atherosclerosis: So far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 2004;24:399-404. (Pubitemid 38326130)
30. Ryan ST, Koteliansky VE, Gotwals PJ et al. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res 2003;40:37-46. (Pubitemid 36351194)
31. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
32. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367.
33. Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-409. (Pubitemid 34407037)
34. Sata M, Fukuda D, Tanaka K et al. The role of circulating precursors in vascular repair and lesion formation. J Cell Mol Med 2005;9:557-568. (Pubitemid 44151947)
35. Massberg S, Konrad I, Schürzinger K et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006;203:1221-1233. (Pubitemid 43736592)
36. Wang CH, Anderson N, Li SH et al. Stem cell factor deficiency is vasculoprotective: Unraveling a new therapeutic potential of imatinib mesylate. Circ Res 2006;99:617-625. (Pubitemid 44401453)
37. Simper D, Stalboerger PG, Panetta CJ et al. Smooth muscle progenitor cells in human blood. Circulation 2002;106:1199-1204. (Pubitemid 34988636)
38. Sartore S, Chiavegato A, Faggin E et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 2001;89:1111-1121. (Pubitemid 34627868)
39. Li G, Chen SJ, Oparil S et al. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000;101:1362-1365. (Pubitemid 30169855)
40. Hu Y, Davison F, Ludewig B et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002;106:1834-1839.
41. Hu Y, Zhang Z, Torsney E et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004;113:1258-1265. (Pubitemid 39069924)
42. Passman JN, Dong XR, Wu SP et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci USA 2008;105:9349-9354.
43. Klein D, Hohn HP, Kleff V et al. Vascular wall-resident stem cells. Histol Histopathol 2010;25:681-689.
44. Xing D, Feng W, Nöt LG et al. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol2058;295:H335-H342.
45. Sata M, Maejima Y, Adachi F et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32:2097-2104.
46. Kimura M, Sudhir K, Jones M et al. Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: Regulation of nitric oxide production by endogenous sex hormones in males. Circ Res 2003;93:1267-1271. (Pubitemid 37543067)
47. Belema-Bedada F, Uchida S, Martire A et al. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008;2:566-575. (Pubitemid 351729213)
48. Gao D, Nolan DJ, Mellick AS et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-198.
49. Flanders KC, Thompson NL, Cissel DS et al. Transforming growth factor-beta 1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108:653-660. (Pubitemid 19065860)
50. Williams AO, Flanders KC, Saffiotti U. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am J Pathol 1993;142:1831-1840. (Pubitemid 24057077)
51. Barcellos-Hoff MH, Ehrhart EJ, Kalia M et al. Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. Am J Pathol 1995;147:1228-1237.
52. Wan M, Yang C, Li J et al. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev 2008;22:2968-2979.
53. Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
54. Li MO, Flavell RA. Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10. Immunity28;2008:468-476. (Pubitemid 351467045)
55. Zhang F, Tsai S, Kato K et al. Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem 2009;284:17564-17574.
56. Schober A, Knarren S, Lietz M et al. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003;108:2491-2497. (Pubitemid 37444411)
57. Schober A, Zernecke A, Liehn EA et al. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res 2004;95:1125-1133. (Pubitemid 39557900)
58. Subramanian P, Karshovska E, Reinhard P et al. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ Res 2010;107:96-105.
59. Nemenoff RA, Simpson PA, Furgeson SB et al. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res 2008;102:1036-1045. (Pubitemid 351667857)
60. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - An intimate relationship. Eur J Cell Biol 2008;87:601-615.
61. Tenney RM, Discher DE. Stem cells, microenvironment mechanics, and growth factor activation. Curr Opin Cell Biol 2009;21:630-635.
62. Worthington JJ, Klementowicz JE, Travis MA. TGFbeta: A sleeping giant awoken by integrins. Trends Biochem Sci 2011;36:47-54.
63. Nishimura SL. Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 2009;175:1362-1370.
64. Hinz B, Gabbiani G. Fibrosis: Recent advances in myofibroblast biology and new therapeutic perspectives. F1000. Biol Rep 2010;2:78.
65. Janssens K, Gershoni-Baruch R, Guañabens N et al. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet 2000;26:273-275.
66. Janssens K, ten DP, Ralston SH et al. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 2003;278:7718-7724.
67. Neptune ER, Frischmeyer PA, Arking DE et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-411. (Pubitemid 36278859)
68. Avvedimento EV, Gabrielli A. Stiff and tight skin: A rear window into fibrosis without inflammation. Sci Transl Med 2010;2:23ps13.
69. Nacher M, Hidalgo A. Fire within the vessels: Interactions between blood cells and inflammatory vascular injury. Front Biosci (Schol Ed) 2011;3:1089-1100.
70. Psaltis PJ, Harbuzariu A, Delacroix S et al. Resident vascular progenitor cells - Diverse origins, phenotype, and function. J Cardiovasc Transl Res 2011;4:161-176.
71. Zengin E, Chalajour F, Gehling UM et al. Vascular wall resident progenitor cells: A source for postnatal vasculogenesis. Development 2006;133:1543-1551. (Pubitemid 43732967)